Application YC di Helix Nanotechnologies

Winter 2017Active

Helix Nanotechnologies ha partecipato a Y Combinator nel batch Winter 2017 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2017
Settore: HealthcareDrug Discovery and Delivery
Dimensione team: 22
Stato: Active
Lanciata: 2016

Founder

Nikolai EroshenkoFounder/CSO

Cosa fa Helix Nanotechnologies

Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button. By focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity. Rigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas. We've started rolling out some of our new tech - moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.

Application YC di Helix Nanotechnologies, ricostruita

Domanda per Y Combinator

Helix Nanotechnologies, batch Winter 2017. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Helix Nanotechnologies

Describe what your company does in 50 characters or less.

Next-generation mRNA platform for disease and climate

What is your company going to make? Please describe your product and what it does or will do.

We are building an mRNA platform that improves the speed and cost of developing therapies. Our technology allows experiments that once took months or years to be done in weeks, and for thousands of dollars instead of millions. We are advancing a COVID-19 vaccine candidate for the immunocompromised and testing an intervention aimed at climate impact.

Where do you live now, and where would the company be based after YC?

We live and work in Boston and Cambridge, MA, and will base the company there after YC.

Explain your decision regarding location.

Boston and Cambridge are biotech hubs with deep scientific talent and collaborators. Being here helps us attract the right team and stay on the cutting edge of RNA technology.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Helix Nanotechnologies?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Helix Nanotechnologies (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Helix Nanotechnologies si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Helix Nanotechnologies?

Helix Nanotechnologies apparteneva al batch Winter 2017 di Y Combinator.

Chi ha fondato Helix Nanotechnologies?

Helix Nanotechnologies è stato fondato da Nikolai Eroshenko.

Cosa fa Helix Nanotechnologies?

Next-generation mRNA platform to solve cancer, COVID and climate.

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Helix Nanotechnologies, e di ogni altro batch YC, è in YC Insights.